Your browser doesn't support javascript.
loading
Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus.
Lu, P; Fleischmann, R; Curtis, C; Ignatenko, S; Clarke, S H; Desai, M; Wong, S L; Grebe, K M; Black, K; Zeng, J; Stolzenbach, J; Medema, J K.
Affiliation
  • Lu P; 1 AbbVie Inc., Worcester, USA.
  • Fleischmann R; 2 Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, USA.
  • Curtis C; 3 Compass Research Center, Orlando, USA.
  • Ignatenko S; 4 Charité Research Organisation, Berlin, Germany.
  • Clarke SH; 1 AbbVie Inc., Worcester, USA.
  • Desai M; 5 AbbVie Inc., North Chicago, USA.
  • Wong SL; 6 AbbVie Biotherapeutics Inc., Redwood City, USA.
  • Grebe KM; 1 AbbVie Inc., Worcester, USA.
  • Black K; 1 AbbVie Inc., Worcester, USA.
  • Zeng J; 5 AbbVie Inc., North Chicago, USA.
  • Stolzenbach J; 5 AbbVie Inc., North Chicago, USA.
  • Medema JK; 7 AbbVie Inc., Cambridge, USA.
Lupus ; 27(2): 290-302, 2018 Feb.
Article in En | MEDLINE | ID: mdl-28691866

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Bridged Bicyclo Compounds, Heterocyclic / Dose-Response Relationship, Drug / Lupus Erythematosus, Systemic Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Middle aged Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Bridged Bicyclo Compounds, Heterocyclic / Dose-Response Relationship, Drug / Lupus Erythematosus, Systemic Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Middle aged Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2018 Document type: Article Affiliation country: Country of publication: